Milking gains

Digesting energy costs, food wins & risks

When the world can't make up its mind

What a week. Markets spent it lurching between relief and fear, never settling on either. First, the relief: the US and Iran's fragile 60-day truce put Iranian oil back on the market, watch us explain - Washington issued a temporary licence to let Iran-sourced oil flow again, helping ease pressure at the bowser. But "fragile" is the key word, the Strait of Hormuz is still disputed, ships are still hesitating, and the clock runs out in August. Enjoy any relief at the pump, but don't bank on it being permanent.

Then markets found something new to panic about: AI - the sell-off that began on Wall Street circled the globe in 24 hours, crashing South Korea nearly 10% and tripping its emergency circuit breaker - proof of just how top-heavy the modern market has become, with a handful of tech giants now the main game in town.

Closer to home, the quiet story: the conflict that sparked the oil drama is costing Aussie companies. In a single morning this week, Worley (ASX:WOR), Mineral Resources (ASX:MIN) and Lotus Resources (ASX:LOT) all pointed at the Middle East - lost sales, stalled projects, even a mothballed lithium mine. A war can feel a world away, right up until it’s economic impact lands on an ASX balance sheet. When uncertainty is everywhere, discipline becomes an investor's greatest advantage.


To your investing,

Biosecurity risks and regulatory wins

This week’s food sector story was split between caution and opportunity. Inghams Group (ASX:ING) is stepping up biosecurity measures in Western Australia after the detection of bird flu in wild birds, a reminder of how quickly biological risks can move from background noise to operational focus for food producers.

At the same time, A2 Milk Company (ASX:A2M) is set to benefit from a long-awaited regulatory approval in China, allowing it to produce premium infant formula in its own facility. Shareholders are also up to receive $300 million from a special dividend. The decision strengthens control over its supply chain and unlocks higher-value production at a pivotal moment for the business.

Commercial traction, pipeline milestones and future catalysts

TSN spoke with Mesoblast (ASX:MSB, Nasdaq:MESO) this week - the company has entered a new chapter following the launch of Ryoncil®, with revenues now approaching US$100 million. For investors the key question is now whether it can translate its scientific platform into sustainable commercial growth and execute on multiple development programs simultaneously. CEO and Managing Director Dr Silviu Itescu discusses the next phase of growth, upcoming milestones and the timelines investors should be watching.

Starpharma (ASX:SPL,US OTC:SPHRY:SPL) - Leading science-led businesses
SPL is operating in a sector defined by long development cycles, evolving data, changing priorities and high expectations. CEO Cheryl Maley discusses what she has learned about leading science-led businesses through change and supporting future-ready STEMM talent.

ETF Education Spotlight - Understanding ETF trading
As ETFs continue to grow in popularity among retail investors, understanding how ETFs actually trade and function has become increasingly important - Global X ETFs’ Jessica Leung explains.

Vinyl Group (ASX:VNL) - Acquiring Pedestrian and Time Out
VNL has moved quickly to reshape its media portfolio, announcing the acquisitions of Pedestrian Group and Time Out Australia within days of each other, after purchasing Val Morgan Digital in March this year. CEO Josh Simons shares the rationale behind the deals, the integration plan and whether further media buys are on the horizon.

ASX Gems: Critical minerals event - Watch here
Critical minerals are increasingly recognised as the building blocks of the modern economy, underpinning industries including electric vehicles, batteries, semiconductors, renewable energy infrastructure and national security systems. Governments across North America, Europe, Asia and Australia are implementing strategies to secure supply of these strategically important commodities.

EQ Resources (ASX:EQR) - Tungsten mining in Far North Queensland
Managing Director Craig Bradshaw outlines the company’s strategy to advance its position as a leading tungsten mining company dedicated to sustainable mining and processing practices. EQR focuses on expanding its world-class tungsten assets at Mt Carbine in Far North Queensland (Australia) and at Barruecopardo in the Salamanca Province (Spain).

Firebird Metals (ASX:FRB) - Advanced lithium manganese battery materials developer
CEO Ron Mitchell outlines the company’s strategy to advance its low-cost, sustainable battery materials by vertically integrating the production of high-purity manganese and next-generation cathode products to support the global electric vehicle and energy storage transition.

Recce Pharmaceuticals (ASX:RCE) - Receives HREC approval
RCE has received Human Research Ethics Committee (HREC) approval to advance its RECCE® 327 Topical Gel (R327G) diabetic foot infection program in Australia to a pivotal Phase 3 clinical trial, strengthening the Company’s global regulatory strategy.

BCAL Diagnostics (ASX:BDX) - Develops BREASTEST Monitor
BDX has developed BREASTEST Monitor, a new blood test designed to help evaluate women for local breast cancer recurrence following treatment, addressing a significant unmet need in post-treatment breast cancer care.

Streamplay Studio (ASX:SP8) - Secures premium publishing partnership
SP8 has entered into a publishing and development support agreement with game developer Sequence Break for a new premium title operating under the working title “Project DS”. The project is currently in development for PC and console platforms and will feature original gameplay systems.

Daly Resources (ASX:DLY) is an Australian exploration company focused on advancing its over 6,300km2 highly prospective wholly owned tenure in the Northern Territory.

Boresight (ASX:BST) delivers an integrated aerial target drone ecosystem that enables realistic counter-UAS training and testing for government and industry.

Li-FT Power (ASX:LFT) is focused on developing a portfolio of hard rock lithium assets in Canada, with core development assets in both Quebec and the Northwest Territories.

Disclaimer

The material contained in this email is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice.

We give no warranty to the accuracy, reliability or completeness of information that is contained in this email and exclude liability for any loss.

This email may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever.

We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this email.